InvestWiser
Stenocare AS
STENO · Nasdaq Copenhagen · Healthcare
0.87DKK
−1.1%last day
Price as of 2 October 2026
Performance
1 month
−3.3%
1 year
−22.7%
3 years, per year
−24.2%
5 years, per year
−32.8%
Largest fall, 3 years
−95.3%
Below the peak now
−95.4%
Volatility, 1 year
96.9%
Return with dividends reinvested.
Key figures
P/E
negative earnings
P/B
4.3
Dividend yield
0.0%
Return on equity
−13.2%
Net margin
−9.8%
Market value
6 m USD
Quality, value and trend
Where Stenocare stands against every Nordic stock today. 100 is best.
57
Profitability and a sound balance sheet over time. Better than 57% of Nordic stocks.
17
The price measured against earnings, assets and cash flow. Better than 17% of Nordic stocks.
18
The price development over the past year. Better than 18% of Nordic stocks.
14
Quality, value and trend together. Better than 14% of Nordic stocks.
About Stenocare
Stenocare AS is a company in healthcare, listed on Nasdaq Copenhagen. The share trades in DKK. It has around 4 employees.
Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally. It offers medical cannabis oil products, including THC, THC/CBD, and CBD, as well as CBD100 oil products. The company was incorporated in 2017 and is based in Randers, Denmark.
See the full analysis in InvestWiser.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
See the full analysis